3rd Non-Viral RNA Delivery Systems Summit
Evvnt Promotion / evvnt
Archivio
01.10.2024 - 03.10.2024 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 9:00 AM - 5:00 PM
Temi della conferenza
There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.
There has been many exciting investments, collaborations and advancements in the field, for instance Capricor Therapeutics and the National Institutes of Health collaborate on a clinical trial for a novel exosome-based vaccine. However, delivery remains the biggest challenge so far for the RNA field, to get drugs to the right cell type with specificity, tolerability and effective targeting.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2422307-3?pid=4832
Speakers: Andrew Geall, Co-Founder and Chief Development Officer, Replicate Bioscience, Anna Perdrix, Founder and Co-Chief Executive Officer, Sixfold Bioscience, and more
URL:
Brochure: https://go.evvnt.com/2422307-3?pid=4832
Speakers: Andrew Geall, Co-Founder and Chief Development Officer, Replicate Bioscience, Anna Perdrix, Founder and Co-Chief Executive Officer, Sixfold Bioscience, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2422307-2?pid=4832
Ms. Lauren Thursby
Medicina General
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
